ACADIA Pharmaceuticals presents at 35th J.P. Morgan Healthcare Conference
ACADIA Pharmaceuticals was chosen to present at the 35th Annual J.P. Morgan Healthcare Conference this year. Read More »
ACADIA Pharmaceuticals was chosen to present at the 35th Annual J.P. Morgan Healthcare Conference this year. Read More »
Sanofi, a global leader in health care and medication distribution, has received FDA approval of Xyzal Allergy 24HR as an over-the-counter medicine. Read More »
The Advisory Committee on Immunization Practices, an extension of the Centers for Disease Control, recommends not using the live influenza vaccine due to poor efficacy. Read More »
The U.S. House of Representative recently passed legislation that increases the role of pharmacists in patient needs by expanded the services that pharmacies offer. Read More »
Allergan PLC recently started See America, a new initiative to combat preventable blindness in the U.S. Read More »
Spartanburg County will receive 60 Opiate Overdose Kits, valued at more than $6,000, from Smith Drug Co. Read More »
Charles Holley Jr. has joined the Amgen Board of Directors as a member of the Audit Committee and the Corporate Responsibility and Compliance Committee. Read More »
Renova Therapeutics Inc. recently entered an alliance with Janssen Pharmaceuticals Inc. for the development of new treatments for congestive heart failure and Type 2 diabetes. Read More »
Five speakers to the Parenteral Drug Association Pharmaceutical Quality Metrics and Culture Conference have been named. Read More »
The National Association of Specialty Pharmacy recently made a new app available for members only. Read More »
The U.S. Food and Drug Administration has accepted Intarcia Therapeutics' New Drug Application for ITCA 650, which can be used to treat Type 2 diabetes. Read More »
Nationwide mail-order pharmacy giant Express Scripts recently revealed successful limits to 2016 drug spending — yielding a 27 percent decrease over that of 2015 — from St. Louis as it released its annual Drug Trend Report. Read More »
Teva Pharmaceutical Industries Ltd., recently announced their intent to market a new drug in the U.S. Read More »
Biotechnology company Acorda Therapeutics Inc., which is known for its work in neurological disorders, will present at two investor conferences this month. Read More »
Kroger will sell Narcan nasal spray in its Dallas and Houston stores, without the need of a prescription. Read More »
President Trump recently met with pharmaceutical executives concerning the prices of drugs and the regulations surrounding them. Read More »
In a letter sent to the U.S. House of Representatives, leaders from Americans for Tax Reform, Citizens Against Government Waste, and the National Taxpayers Union, urged congressional members to "oppose any attempts to change the successful and cost-saving process by which drug prices are negotiated for Medicare Part D." Read More »
Walgreens Boots Alliance and Rite Aid recently came to an agreement on a price reduction for the purchase of Rite Aid. Read More »
Digital Pharmacist Inc. was launched Jan. 31 after the strategic merger of TeleManager Technologies Inc. and RxWiki Inc. Read More »
Sanofi has received FDA approval of Xyzal Allergy 24HR, an over-the-counter option for those suffering with certain allergies. Read More »